Anthony N Karnezis

Anthony N Karnezis

UNVERIFIED PROFILE

Are you Anthony N Karnezis?   Register this Author

Register author
Anthony N Karnezis

Anthony N Karnezis

Publications by authors named "Anthony N Karnezis"

Are you Anthony N Karnezis?   Register this Author

53Publications

1684Reads

20Profile Views

Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.

Histopathology 2020 Jan;76(1):11-24

Clinical Cancer Genomics Laboratory and Pathology Department, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13978DOI Listing
January 2020

Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.

Int J Gynecol Pathol 2019 Nov;38(6):552-561

British Columbia Cancer Agency (J.M., A.N.K., A.T., D.C., D.G.H.) Department of Pathology, University of British Columbia (A.N.K., B.T.-C., C.C., A.C., C.B.G., D.G.H.), Vancouver, British Columbia, Canada Memorial Sloan Kettering Cancer Center, New York, New York (R.S.) Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands (S.H.) Department of Women's Health, Tübingen University Hospital, Tübingen (S.K.) Department of Gynecologic Oncology, Kliniken Essen Mitte, Essen (A.D.B.) Gynecologic Oncology Center, Kiel (J.P.) Institute of Pathology, Friedrichshafen (F.K.), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000538DOI Listing
November 2019

Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers.

Hum Pathol 2019 Oct 18;92:39-47. Epub 2019 Jun 18.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V5Z 1L3, Canada; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.06.001DOI Listing
October 2019

Bartholin Gland Carcinoma: Clinicopathologic Features, Including p16 Expression and Clinical Outcome.

Int J Gynecol Pathol 2019 Mar;38(2):189-195

Department of Pathology and Laboratory Medicine (T.N., A.S.C., A.N.K., C.B.G.) Genetic Pathology Evaluation Centre (A.S.C.), University of British Columbia Division of Anatomical Pathology, Vancouver General Hospital (T.N., A.N.K., C.B.G.) Division of Medical Oncology, British Columbia Cancer Agency (A.T.), Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9922
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000489DOI Listing
March 2019

DICER1 hot-spot mutations in ovarian gynandroblastoma.

Histopathology 2018 Aug 5;73(2):306-313. Epub 2018 Jun 5.

Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13630DOI Listing
August 2018

High Frequency of Ovarian Cyst Development in Vhl;Snf5 Mice.

Am J Pathol 2018 07 22;188(7):1510-1516. Epub 2018 Apr 22.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024179PMC
July 2018

Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation.

Pathology 2018 Feb 17;50(2):238-256. Epub 2018 Jan 17.

University of California San Francisco, Pathology Department, San Francisco, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2017.10.009DOI Listing
February 2018

Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Clin Obstet Gynecol 2017 12;60(4):789-800

*Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada †Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0000000000000312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843373PMC
December 2017

Detection and genomic characterization of a mammary-like adenocarcinoma.

Cold Spring Harb Mol Case Stud 2017 Nov 21;3(6). Epub 2017 Nov 21.

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701302PMC
November 2017

Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.

Histopathology 2017 Aug 23;71(2):238-246. Epub 2017 May 23.

Department of Pathology and Laboratory Medicine, University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13205DOI Listing
August 2017

The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.

J Pathol 2017 07 2;242(3):371-383. Epub 2017 Jun 2.

Department of Pathology and Laboratory Medicine, University of British Columbia and Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/path.4912
Publisher Site
http://dx.doi.org/10.1002/path.4912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857704PMC
July 2017

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.

Cancer 2017 03 6;123(5):802-813. Epub 2017 Jan 6.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30496DOI Listing
March 2017

The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Nat Rev Cancer 2017 01 25;17(1):65-74. Epub 2016 Nov 25.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc.2016.113DOI Listing
January 2017

Of mice and women - Non-ovarian origins of "ovarian" cancer.

Gynecol Oncol 2017 01 24;144(1):5-7. Epub 2016 Nov 24.

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.11.039DOI Listing
January 2017

Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.

Mod Pathol 2016 12 26;29(12):1586-1593. Epub 2016 Aug 26.

Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.156DOI Listing
December 2016

Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.

Histopathology 2016 Oct 5;69(4):560-9. Epub 2016 Jul 5.

Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12989DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516928PMC
October 2016

Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.

Sci Rep 2016 10 7;6:34949. Epub 2016 Oct 7.

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep34949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054533PMC
October 2016

p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.

Int J Gynecol Pathol 2016 Jul;35(4):385-93

Department of Cellular Pathology (S.J., N.S.), Barts Health NHS Trust, London, United Kingdom Department of Pathology and Laboratory Medicine (A.S.C., A.N.K., C.B.G.), Vancouver General Hospital Department of Obstetrics and Gynecology (J.N.M.), Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000263DOI Listing
July 2016

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.

J Natl Cancer Inst 2016 Jun 1;108(6):djv428. Epub 2016 Feb 1.

Department of Pathology and Laboratory Medicine, (MSA, HMH, JS, HLC, ANK, BSS, MKM, CBG, SK, DGH) and Department of Obstetrics and Gynaecology (MSA, DGH), University of British Columbia, Vancouver, Canada; Department of Molecular Oncology, British Columbia Cancer Agency Cancer Research Centre, Vancouver, Canada (YKW, AB, RM, DSG, SPS); Department of Women's Health, University Hospital Tuebingen, Tuebingen, Germany (MM, FAT, DW, SB, SK); Division of Anatomic Pathology, Synlab MVZ, Institute of Pathology, Mannheim, Germany (FK); Division of Gynecologic Pathology, Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany (AS); Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, Canada (CBG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv428DOI Listing
June 2016

The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.

Gynecol Oncol 2016 06 19;141(3):454-460. Epub 2016 Mar 19.

Department of Human Genetics, McGill University, Montreal, QC, Canada; Lady Davis Institute and Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada; Department of Medical Genetics and Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876126PMC
June 2016

Comprehensive genomic profiles of small cell lung cancer.

Nature 2015 Aug 13;524(7563):47-53. Epub 2015 Jul 13.

1] Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, 50931 Cologne, Germany. [2] Department of Pathology, University Hospital Cologne, 50937 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861069PMC
August 2015

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Am J Surg Pathol 2014 Jun;38(6):793-800

Departments of *Pathology ‡Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco †Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/06000/Association_of_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000177DOI Listing
June 2014

RAS transformation requires CUX1-dependent repair of oxidative DNA damage.

PLoS Biol 2014 Mar 11;12(3):e1001807. Epub 2014 Mar 11.

Goodman Cancer Centre, McGill University, Montreal, Quebec, Canada; Department of Biochemistry, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Oncology McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.1001807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949673PMC
March 2014

Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.

Mod Pathol 2013 Oct 24;26(10):1279-87. Epub 2013 May 24.

Neuropathology Unit, Department of Anatomic Pathology, UCSF School of Medicine, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.79DOI Listing
October 2013

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Mod Pathol 2013 Sep 5;26(9):1255-63. Epub 2013 Apr 5.

Department of Obstetrics and Gynecology, Division of Gynecological Oncology, Winnipeg Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.55DOI Listing
September 2013

Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.

Genes Dev 2013 Mar;27(5):504-13

Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143-0502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.205542.112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605464PMC
March 2013

Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma.

Am J Surg Pathol 2013 Jan;37(1):24-37

Department of Pathology, University of California San Francisco, San Francisco, CA 94143-0102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31826a5399DOI Listing
January 2013

Endogenous Myc maintains the tumor microenvironment.

Genes Dev 2011 May 8;25(9):907-16. Epub 2011 Apr 8.

Department of Pathology, University of California at San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.2038411DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084025PMC
May 2011

Selective activation of p53-mediated tumour suppression in high-grade tumours.

Nature 2010 Nov;468(7323):567-71

University of California San Francisco, Department of Pathology and Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94143-0502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature09526DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011233PMC
November 2010

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Nat Genet 2009 May 12;41(5):544-52. Epub 2009 Mar 12.

Cancer Research Institute & Department of Cell and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705918PMC
May 2009

Modelling Myc inhibition as a cancer therapy.

Nature 2008 Oct 17;455(7213):679-83. Epub 2008 Aug 17.

Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143-0875, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature07260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485609PMC
October 2008

Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.

Nat Genet 2008 Oct 31;40(10):1240-4. Epub 2008 Aug 31.

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, Cancer Research Institute, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654781PMC
October 2008

Misclassification of bronchioloalveolar carcinoma with cytologic diagnosis of lung cancer.

J Thorac Oncol 2006 Nov;1(9):943-8

Department of Surgery, Division of Cardiothoracic Surgery and the UCSF Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94131, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497593PMC
November 2006